AbCellera Biologics Inc. (ABCL)
Market Closed
3 Jun, 20:00
$
5. 7200
-0.41
-6.69%
$
1.66B Market Cap
- P/E Ratio
- Div Yield
5,387,001 Volume
-0.47 Eps
$ 6.13
Previous Close 
Want to track ABCL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Down 57%, Is AbCellera Biologics a Buy on the Dip?
AbCellera Biologics is a biotechnology company built to discover new antibodies for other drugmakers. The stock has fallen more than 90% from its all-time high and by 57% from a peak it set last summer.
Fool | 1 year ago
